EA200802412A1 - Терапевтические комбинации для сопровождающихся болью медицинских состояний - Google Patents
Терапевтические комбинации для сопровождающихся болью медицинских состоянийInfo
- Publication number
- EA200802412A1 EA200802412A1 EA200802412A EA200802412A EA200802412A1 EA 200802412 A1 EA200802412 A1 EA 200802412A1 EA 200802412 A EA200802412 A EA 200802412A EA 200802412 A EA200802412 A EA 200802412A EA 200802412 A1 EA200802412 A1 EA 200802412A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- medical conditions
- therapeutic combinations
- agent
- supporting medical
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81185906P | 2006-06-08 | 2006-06-08 | |
US81184006P | 2006-06-08 | 2006-06-08 | |
PCT/EP2006/008171 WO2007020103A2 (fr) | 2005-08-18 | 2006-08-18 | Nouvelle utilisation de composes peptidiques pour traiter une douleur musculaire |
US11/506,524 US20070043120A1 (en) | 2005-08-18 | 2006-08-18 | Therapeutic combination for painful medical conditions |
US11/506,523 US20070197657A1 (en) | 2005-08-18 | 2006-08-18 | Method for treating non-inflammatory musculoskeletal pain |
US11/506,578 US20070048372A1 (en) | 2005-08-18 | 2006-08-18 | Method for treating non-inflammatory osteoarthritic pain |
US11/506,577 US20070042969A1 (en) | 2004-03-26 | 2006-08-18 | Combination therapy for pain in painful diabetic neuropathy |
PCT/EP2007/005036 WO2007141018A1 (fr) | 2006-06-08 | 2007-06-06 | Combinaison thérapeutique pour états médicaux douloureux |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200802412A1 true EA200802412A1 (ru) | 2009-06-30 |
Family
ID=46964866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200802412A EA200802412A1 (ru) | 2006-06-08 | 2007-06-06 | Терапевтические комбинации для сопровождающихся болью медицинских состояний |
Country Status (11)
Country | Link |
---|---|
JP (1) | JP2009539792A (fr) |
KR (1) | KR20090018863A (fr) |
AR (1) | AR061250A1 (fr) |
AT (1) | ATE530175T1 (fr) |
AU (1) | AU2007256352A1 (fr) |
BR (1) | BRPI0712494A2 (fr) |
CA (1) | CA2652667A1 (fr) |
EA (1) | EA200802412A1 (fr) |
MX (1) | MX2008015341A (fr) |
TW (1) | TW200814988A (fr) |
WO (1) | WO2007141018A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200846002A (en) * | 2007-03-15 | 2008-12-01 | Astellas Pharma Inc | Novel prophylactic and/or therapeutic agent for diabetic neuropathy |
TW200846003A (en) * | 2007-03-15 | 2008-12-01 | Astellas Pharma Inc | Novel prophylactic and/or therapeutic agent for diabetic neuropathy |
EP2116539A1 (fr) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles en tant que ligands améliorant les effets analgésiques des opioïdes et réduisant leur dépendance |
US20110152268A1 (en) * | 2008-09-11 | 2011-06-23 | Astellas Pharma Inc. | Novel pharmaceutical composition for treating nociceptive pain |
US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
EP2353598A1 (fr) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Ligands sigma pour utilisation dans la prévention et/ou le traitement de la douleur post-opératoire |
EP2353591A1 (fr) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Ligands sigma pour la potentialisation de l'effet analgésique d'opioïdes et d'opiacés dans la douleur post-opératoire et en atténuant la dépendance |
EP2388005A1 (fr) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Ligands sigma pour la prévention et/ou le traitement du vomissement induit par la chimiothérapie ou la radiothérapie |
SI2582366T1 (sl) | 2010-06-15 | 2016-02-29 | Gruenenthal Gmbh | Farmacevtska kombinacija za zdravljenje bolečine |
EP2415471A1 (fr) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Utilisation de ligands sigma dans l'hyperalgie induite par opioïdes |
EP2524694A1 (fr) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Utilisation de ligands sigma dans la douleur liée au diabète de type 2 |
US9662305B2 (en) | 2012-11-20 | 2017-05-30 | Revive Therapeutics Inc. | Use of bucillamine in the treatment of gout |
JP2015537009A (ja) * | 2012-11-20 | 2015-12-24 | リバイブ・セラピューティクス・インコーポレイテッド | 痛風の治療におけるブシラミンの使用 |
BR112016013754A2 (pt) | 2013-12-17 | 2017-08-08 | Esteve Labor Dr | Recaptação de serotonina-norepinefrina inibidores (irsns) e combinações dos ligantes do receptor sigma |
CN114306346A (zh) * | 2021-12-14 | 2022-04-12 | 四川大学华西医院 | 拉莫三嗪在治疗系统性红斑狼疮中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60120104T2 (de) * | 2001-03-20 | 2006-09-21 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz |
KR20060111524A (ko) * | 2003-12-02 | 2006-10-27 | 쉬바르츠파르마에이지 | 펩타이드 화합물들의 중추 신경병증성 통증 치료를 위한신규한 용도 |
EP1579858A1 (fr) * | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Nouvelle utilisation de peptides pour le traitement de la neuropathie diabètique |
CN1950101B (zh) * | 2004-04-16 | 2011-03-30 | 舒沃茨药物股份公司 | 肽化合物用于预防和治疗慢性头痛的用途 |
RU2006139930A (ru) * | 2004-05-03 | 2008-06-10 | Дюк Юниверсити (Сша/Сша) (Us) | Составы для содействия снижению веса |
-
2007
- 2007-06-06 WO PCT/EP2007/005036 patent/WO2007141018A1/fr active Application Filing
- 2007-06-06 EA EA200802412A patent/EA200802412A1/ru unknown
- 2007-06-06 MX MX2008015341A patent/MX2008015341A/es unknown
- 2007-06-06 AU AU2007256352A patent/AU2007256352A1/en not_active Abandoned
- 2007-06-06 AT AT07725884T patent/ATE530175T1/de not_active IP Right Cessation
- 2007-06-06 JP JP2009513597A patent/JP2009539792A/ja active Pending
- 2007-06-06 BR BRPI0712494-5A patent/BRPI0712494A2/pt not_active IP Right Cessation
- 2007-06-06 KR KR1020097000247A patent/KR20090018863A/ko not_active Application Discontinuation
- 2007-06-06 AR ARP070102440A patent/AR061250A1/es not_active Application Discontinuation
- 2007-06-06 CA CA002652667A patent/CA2652667A1/fr not_active Abandoned
- 2007-06-07 TW TW096120539A patent/TW200814988A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AR061250A1 (es) | 2008-08-13 |
JP2009539792A (ja) | 2009-11-19 |
ATE530175T1 (de) | 2011-11-15 |
TW200814988A (en) | 2008-04-01 |
WO2007141018A1 (fr) | 2007-12-13 |
MX2008015341A (es) | 2009-02-10 |
CA2652667A1 (fr) | 2007-12-13 |
BRPI0712494A2 (pt) | 2012-10-09 |
AU2007256352A1 (en) | 2007-12-13 |
KR20090018863A (ko) | 2009-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
WO2011014255A8 (fr) | Traitement de la maladie de crohn au moyen de laquinimod | |
RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
EA200970935A1 (ru) | Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа | |
IL192100A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain | |
EA200800798A1 (ru) | Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха | |
SI2205244T1 (sl) | Postopki dajanja N-(5-terc.-butil-izoksazol-3-il)-N'-(4-(7-(2-morfolin- 4-il-etoksi-)imidazo-2,1-b)-(1,3)-benzotiazol-2-il)-fenil)sečnine za zdravljenje proliferativne bolezni | |
MA33076B1 (fr) | Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer | |
EA201490254A1 (ru) | Комбинированное лечение гепатита с | |
EA201290859A1 (ru) | Лечение люпус-артрита с использованием лаквинимода | |
EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
EA201071038A1 (ru) | Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
EA201300421A1 (ru) | Комбинированная терапия для лечения инфекции hcv | |
SE0400184D0 (sv) | New therapeutical use | |
WO2008070010A3 (fr) | Rétablissement après une attaque | |
MX2008002456A (es) | Uso de ambroxol para el tratamiento de infecciones por rinovirus. | |
EA200970127A1 (ru) | Модулятор рецепторов глюкокортикостероидов и способы его применения | |
TNSN08506A1 (en) | Substituted carboxamides | |
DK1732551T3 (da) | Perhexilin til behandling af kronisk hjertesvigt | |
EA201071350A1 (ru) | Композиции и способы для лечения воспаления роговицы | |
WO2006133231A3 (fr) | Traitement de maladies neurodegeneratives | |
MX2009006670A (es) | Composicion farmaceutica que usa el aliskiren y el avosentan. | |
DE112006002041A5 (de) | Pharmazeutisch wirksame Zusammensetzung zur Behandlung von Diabetes | |
ATE468852T1 (de) | Lofexidine zur intraspinalen anwendung | |
RU2010144554A (ru) | Средство для предотвращения и/или лечения сосудистых заболеваний |